ADAMAS PHARMACEUTICALS
Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia. The company was incorporated in 2000 and is headquartered in Emeryville, California with operations in India, the United States, and Singapore.
ADAMAS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.adamaspharma.com
Total Employee:
11+
Status:
Active
Contact:
5104280519
Email Addresses:
[email protected]
Total Funding:
141.2 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail IPv6 ReCAPTCHA JsDelivr Microsoft Azure DNS Cloudflare JS
Similar Organizations
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals focuses on the development and commercialization of therapies for the treatment of pain and other conditions.
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Allena Pharmaceuticals
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aragon Pharmaceuticals
Aragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Arsenal Medical
Arsenal Medical develops novel products that improve local therapy for injuries and diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Beryllium Discovery
Beryllium Discovery is a specialized drug discovery contract research organization (CRO), provides research services.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Conatus Pharmaceuticals
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
VYNE Therapeutics
VYNE Therapeutics developing proprietary, innovative and differentiated therapies in dermatology and beyond.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
moksha8 Pharmaceuticals
Moksha8 is a pharmaceutical company providing therapeutics for the treatment of central nervous system and mental health disorders.
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Reven Pharmaceuticals
Reven Pharmaceuticals is a clinical-stage company providing solutions for the treatment of vascular and metabolic-related conditions.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sea Pharmaceuticals
Sea Pharmaceuticals is a neurological therapeutics R&D company creating and delivering innovative treatments for ALS and other disorders.
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
Theragene Pharmaceuticals
Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.
USMD
USMD Holdings develops, operates and manages entities that deliver diagnostic, therapeutic and hospital-based health care to patients.
Vaccinogen
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.
Valitor
Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..
ZY Therapeutics
ZY Therapeutics develops a drug delivery platform for cancer therapeutics using nanotechnology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 1996-07-30 | Future Domain | Future Domain acquired by Adamas Pharmaceuticals | N/A |
Investors List
Northgate Capital
Northgate Capital investment in Series D - Adamas Pharmaceuticals
DAG Ventures
DAG Ventures investment in Series D - Adamas Pharmaceuticals
Aeris Capital
Aeris Capital investment in Series D - Adamas Pharmaceuticals
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Series D - Adamas Pharmaceuticals
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Series B - Adamas Pharmaceuticals
Official Site Inspections
http://www.adamaspharma.com
- Host name: ec2-3-214-152-230.compute-1.amazonaws.com
- IP address: 3.214.152.230
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
